+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Glucose Monitoring Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666055
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood Glucose Monitoring Market grew from USD 14.08 billion in 2024 to USD 15.27 billion in 2025. It is expected to continue growing at a CAGR of 8.38%, reaching USD 22.82 billion by 2030.

Blood glucose monitoring serves as the cornerstone of effective diabetes management, enabling timely adjustments to therapy and lifestyle. From self-monitoring at home to continuous tracking in clinical settings, these technologies empower patients and healthcare providers with actionable data. Over recent years, the convergence of miniaturized sensors, wireless connectivity, and data analytics has transformed simple glucometers into sophisticated platforms that drive personalized care. As the prevalence of diabetes continues to rise globally, the demand for more accurate, less invasive, and user-friendly solutions intensifies. This executive summary introduces the evolving landscape of blood glucose monitoring, highlighting key technological advances, regulatory drivers, and emerging market dynamics. By exploring critical shifts, tariff impacts, segmentation nuances, regional trends, and competitive forces, decision-makers can better anticipate strategic priorities and align investments with prevailing opportunities. Throughout this report, we maintain a professional tone and evidence-based approach, ensuring clarity and relevance for experts and senior executives seeking a comprehensive overview of this vital healthcare sector.

Transformative Shifts in the Landscape

The blood glucose monitoring arena is experiencing transformative shifts propelled by innovation and shifting patient expectations. Continuous glucose monitoring platforms now integrate seamlessly with smartphones, delivering real-time alerts and predictive analytics that preempt hypo- or hyperglycemic events. Non-invasive technologies leveraging photometric or optical methods are advancing through clinical validation, offering the promise of pain-free measurement. Simultaneously, the rise of wearable devices and cloud-based data ecosystems supports remote patient monitoring and telehealth models, enabling clinicians to manage therapy without in-person visits. Artificial intelligence and machine learning algorithms enhance trend analysis, glycemic forecasting, and personalized treatment plans. Regulatory frameworks have adapted, with faster approvals for breakthrough devices and clearer guidelines for digital health interoperability. Moreover, heightened focus on pre-diabetes management and gestational diabetes screening drives demand for accessible point-of-care solutions. Collectively, these dynamics are redefining patient engagement, care pathways, and value propositions across the blood glucose monitoring landscape.

Cumulative Impact of United States Tariffs 2025

In 2025, the United States implemented revised tariff schedules affecting imported medical devices and components integral to blood glucose monitoring systems. Increased duties on sensors, transmitters, and photometric modules have elevated manufacturing costs, prompting leading suppliers to reassess global supply chains. Companies reliant on overseas production have initiated strategic shifts, including near-shoring and diversification to mitigate tariff exposure. Higher input costs have translated into modest price adjustments for end users, creating cost-sensitivity pressures within insurance reimbursement models. Additionally, domestic manufacturers are exploring local partnerships to align with ‘Made in USA’ incentives, further altering competitive dynamics. While short-term supply chain disruptions and inventory realignments have emerged, the mid-term outlook suggests a stabilized operational environment as firms optimize sourcing and adjust product portfolios. Overall, the cumulative impact of these tariffs underscores the importance of agile procurement strategies and investment in cost-effective technologies to sustain growth in a more protectionist trade context.

Key Segmentation Insights

A nuanced understanding of market segmentation reveals where innovation and demand converge most strongly. In the product type realm, continuous glucose monitoring solutions command attention with subcategories encompassing receivers and monitors, sensors, and transmitters, while invasive and non-invasive options address different patient preferences. Component analysis highlights core revenue streams from blood glucose meters, control solutions, lancets, and test strips, each playing distinct roles in routine and emergent monitoring. Therapeutic approach segmentation differentiates between gestational diabetes screening, intensive type 1 diabetes management for adult and pediatric patients, and type 2 diabetes strategies that span early pre-diabetes interventions through advanced disease states. End-user channels range from specialized diagnostic centers to homecare environments and hospitals or clinics, with cardiology, endocrinology, and general hospital settings shaping purchase patterns. Distribution pathways include diabetic clinics, hospital pharmacies, online pharmacies, and retail pharmacies, each offering unique access points. Technological divisions separate smartphone-compatible devices from wearables, while age group analysis contrasts adult and pediatric usage trends. Application categories cover continuous monitoring, daily spot checks, and diagnostic testing, intersecting with device types such as disposable strips, handheld meters, and fully wearable trackers. Finally, measurement methods split between electrochemical sensing and photometric analysis, each underpinning different accuracy and cost profiles. This comprehensive segmentation framework illuminates strategic growth areas and potential gaps in product portfolios.

Key Regional Insights

Regional dynamics shape competitive intensity and adoption rates across three primary markets. In the Americas, high healthcare spending and favorable reimbursement programs drive rapid uptake of advanced continuous monitoring platforms, bolstered by strong patient advocacy networks. Meanwhile, Europe, the Middle East & Africa exhibit heterogeneous demand-Western Europe leads with integrated digital health initiatives and progressive regulatory pathways, while emerging markets in Eastern Europe and the Middle East prioritize cost-effective invasive glucometers and robust distribution partnerships. In the Asia-Pacific region, rising diabetes prevalence, expanding middle-class populations, and government screening programs fuel growth; China and India emerge as critical battlegrounds for both global and local manufacturers. Supply chain strategies also vary by region, with Asia-Pacific serving as a major production hub, Europe emphasizing quality certifications, and the Americas focusing on localized assembly. Understanding these regional contrasts allows stakeholders to tailor market entry, pricing, and product development strategies for maximum impact.

Key Companies Insights

The competitive landscape features a mix of global medical device giants and specialized innovators. Abbott Laboratories and Dexcom, Inc. lead in sensor technology, while F. Hoffmann-La Roche Ltd. and Medtronic PLC maintain strong portfolios spanning meters to integrated pump systems. Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., and Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation anchor the traditional meter segment, complemented by ARKRAY, Inc. and B. Braun Melsungen AG. Bayer AG and Becton, Dickinson and Company excel in consumables such as test strips and lancets. Emerging players like Insulet Corporation, Senseonics Holdings Inc., and Nemaura Medical Inc. introduce innovative wearables and non-invasive devices. Additional contributors include Advin Health Care, AdvaCare Pharma, GlySens Incorporated, I-SENS, Inc., Medtrum Technologies Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG. Collaboration, mergers and acquisitions, and strategic partnerships continue to redefine market share, while sustained investment in R&D accelerates the pace of technological advancement.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a multi-pronged strategy to capture emerging opportunities. Prioritize development of interoperable continuous glucose monitoring systems with open APIs to foster ecosystem partnerships and integrate seamlessly into telehealth platforms. Invest in next-generation non-invasive and photometric sensors to address patient adherence challenges and broaden market reach. Strengthen supply chain resilience by diversifying manufacturing locations and establishing strategic alliances with contract producers to mitigate trade policy risks. Enhance distribution networks by forging collaborations with hospital pharmacies, online platforms, and specialty diabetic clinics to optimize patient access. Leverage real-world data analytics to demonstrate clinical and cost benefits, supporting more favorable reimbursement decisions. Expand targeted campaigns in high-growth regions by aligning product portfolios with local regulations and health initiatives. Lastly, explore subscription-based models and remote monitoring services to build recurring revenue streams and deepen patient engagement, ensuring a balanced portfolio of hardware, software, and service offerings.

Conclusion

In summary, the blood glucose monitoring market stands at an inflection point driven by technological innovation, evolving trade policies, and diverse end-user needs. Continuous glucose monitoring and non-invasive methods are redefining standard care, while tariff adjustments in the United States underscore the need for agile supply chain management. A comprehensive segmentation approach reveals targeted growth opportunities across product types, therapeutic approaches, and distribution channels, and regional insights highlight distinct market characteristics in the Americas, Europe, Middle East & Africa, and Asia-Pacific. Established medical device leaders and agile newcomers alike are investing heavily in R&D, partnerships, and digital integration to maintain competitive advantage. As the sector continues to evolve, stakeholders must remain vigilant, data-driven, and patient-centered to capitalize on emerging trends and address unmet needs.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Continuous Glucose Monitors (CGMs)
    • Receivers & Monitors
    • Sensors
    • Transmitters
  • Invasive Blood Glucose Monitoring
  • Non-Invasive Blood Glucose Monitors
  • Blood Glucose Meters
  • Control Solutions
  • Lancets
  • Test Strips
  • Gestational Diabetes
  • Type 1 Diabetes
    • Adult Patients
    • Pediatric Patients
  • Type 2 Diabetes
    • Pre-Diabetes Management
  • Diagnostic Centers
  • Homecare Settings
  • Hospitals & Clinics
    • Cardiology Clinics
    • Endocrinology Clinics
    • General Hospitals
  • Diabetic Clinics
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Smartphone-Compatible Devices
  • Wearable Devices
  • Adult
  • Pediatrics
  • Continuous Monitoring
  • Daily Monitoring
  • Diagnostic Testing
  • Disposable
  • Handheld
  • Wearable
  • Electrochemical
  • Photometric

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood Glucose Monitoring Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • AdvaCare Pharma
  • Advin Health Care
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • B. Braun Melsungen AG
  • BAYER AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Incorporated
  • I-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holding, LLC.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Novo Nordisk A/s
  • NXP Semiconductors N.V.
  • PHC Holding Corporation
  • Prodigy Diabetes Care LLC
  • Sanofi S.A.
  • Senseonics Holdings Inc.
  • Sinocare Inc.
  • Teladoc Health, Inc.
  • Terumo Corporation
  • Ypsomed AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of diabetes and improved awareness programs
5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
5.1.2. Restraints
5.1.2.1. Adverse recalls of blood glucose monitoring systems
5.1.3. Opportunities
5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
5.1.4. Challenges
5.1.4.1. Complexity in the production and operation of blood glucose monitoring
5.2. Market Segmentation Analysis
5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Blood Glucose Monitoring Market, by Product
6.1. Introduction
6.2. Continuous Blood Glucose Monitors
6.2.1. Insulin Pumps
6.2.2. Sensors
6.2.3. Transmitter & Receiver
6.3. Self or One Time Monitors
6.3.1. Blood Glucose Meter
6.3.2. Lancets
6.3.3. Testing Strips
7. Blood Glucose Monitoring Market, by Testing Technology
7.1. Introduction
7.2. Electrode Type Blood Glucose Monitor
7.3. Photoelectric Blood Glucose Monitor
8. Blood Glucose Monitoring Market, by Application
8.1. Introduction
8.2. Gestational Diabetes
8.3. Type 1 Diabetes
8.4. Type 2 Diabetes
9. Blood Glucose Monitoring Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Blood Glucose Monitoring Market, by End-User
10.1. Introduction
10.2. Home Care
10.3. Hospital & Clinics
11. Americas Blood Glucose Monitoring Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Blood Glucose Monitoring Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Blood Glucose Monitoring Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 55. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 56. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 92. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 93. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 99. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 100. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 113. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 114. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 155. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 156. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 175. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 177. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 178. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 184. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 185. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 191. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 192. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 198. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 206. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 219. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 220. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 240. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 247. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 248. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 254. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 255. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 281. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 282. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 283. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 303. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 304. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. UNITED KING

Companies Mentioned

  • Abbott Laboratories
  • AdvaCare Pharma
  • Advin Health Care
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • B. Braun Melsungen AG
  • BAYER AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Incorporated
  • I-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holding, LLC.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Novo Nordisk A/s
  • NXP Semiconductors N.V.
  • PHC Holding Corporation
  • Prodigy Diabetes Care LLC
  • Sanofi S.A.
  • Senseonics Holdings Inc.
  • Sinocare Inc.
  • Teladoc Health, Inc.
  • Terumo Corporation
  • Ypsomed AG

Methodology

Loading
LOADING...